EMA press briefing to update on analysis of data on Vaxzevria, the COVID-19 vaccine from AstraZeneca
Table of contents
Date:
23/04/2021
Location:
Virtual meeting
EMA is holding a virtual press briefing to provide an update on the analysis of data on Vaxzevria, the COVID-19 vaccine from AstraZeneca, and the interim opinion issued today by EMA’s human medicines committee, CHMP, aimed at supporting national decision-making on how to best use the vaccine in their territories.
Speakers include:
- Noël Wathion (Deputy Executive Director)
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Peter Arlett (Head of Data Analytics and Methods Task Force)
The press briefing will be moderated by Marie-Agnes Heine (Head of Communication).
The press briefing will be held in English.